Astragaloside IV, another TCM bioactive, attenuates atherosclerosis via the PI3K/Akt/mTOR pathway activation, reducing oxidative stress and improving lipid metabolism in apoE−/− models, further underscoring the multi-target potential of TCM [195]. Here, AKT1 is linked to atherosclerosis.